← Back to headlines
India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
18 Mar, 00:30 — 18 Mar, 00:30
Sources
Showing 1 of 1 sources
Related Stories
Negative Trendwende: Um die psychische Gesundheit von Schülern steht es wieder schlechter
14m ago
Enkel metode kan hjelpe mot IBS-plagene: – Mange merker bedring
14m ago
Fire suspected to have originated from electric car kills 6 members of Indore family
40m ago
Vietnamese trio caught setting up ecstasy lab in Korea after learning how to make it via ChatGPT
41m ago